✦ LIBER ✦

Interim safety analysis of a randomized phase III study evaluating pegylated liposomal doxorubicin (PLD) versus capecitabine as first line chemotherapy for metastatic breast cancer (MBC) – The PELICAN study

✍ Scribed by S. Al-Batran; S. Saupe; A. Kerber; H.J. Lueck; C. Jackisch; M. Untch; M. Schmidt; E. Jager; N. Harbeck

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase III study comparing p

✍ Smorenburg, C. H.; de Groot, S. M.; van Leeuwen-Stok, A. E.; Hamaker, M. E.; Wym 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 218 KB

5075 POSTER Non-pegylated Liposomal Doxo

✍ Imperatori, L.; Lippe, P.; Trapuzzano, C.; Laid, G.; Cappelletti, C.; Tamburrano 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A Phase II Randomized Crossover Study of

✍ Denise A. Yardley; Howard A. Burris III; David R. Spigel; Bobby L. Clark; Elizab 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 359 KB

Capecitabine plus paclitaxel versus epir

✍ Hans-Joachim Lück, Andreas Du Bois, Sibylle Loibl, Iris Schrader, Jens Huober, V 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 279 KB

2130 POSTER Updated analysis of an inter

✍ N. Tubiana-Mathieu; P. Bougnoux; D. Becquart; A. Chan; F. Majois; M. Espie; O. P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

6600 POSTER A Randomized, Multicenter, O

✍ Zhang, X.; Shen, L.; Lu, Z.; Hu, B.; Fan, Q.; Li, W.; Liu, W.; Liu, T.; Pan, Y.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB